Anika Therapeutics IncNASDAQ:ANIK
- LAST PRICE21.8928
- TODAY'S CHANGE (%)0.5128 (2.3985%)
- Bid / Lots21.8600/ 2
- Ask / Lots21.9600/ 4
- Open / Previous Close21.4500 / 21.3800
- Day Range
- 52 Week Range
- Volume39,051
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ANIK |
|---|---|---|
| 09:32 ET | 480 | 21.45 |
| 09:42 ET | 370 | 21.5 |
| 09:50 ET | 400 | 21.318 |
| 09:51 ET | 200 | 21.315 |
| 09:53 ET | 200 | 21.31 |
| 09:55 ET | 100 | 21.325 |
| 09:57 ET | 100 | 21.25 |
| 10:00 ET | 200 | 21.325 |
| 10:02 ET | 200 | 21.245 |
| 10:04 ET | 100 | 21.325 |
| 10:06 ET | 100 | 21.255 |
| 10:08 ET | 300 | 21.325 |
| 10:15 ET | 867 | 21.3 |
| 10:18 ET | 100 | 21.34 |
| 10:20 ET | 200 | 21.38 |
| 10:22 ET | 620 | 21.48 |
| 10:24 ET | 200 | 21.5 |
| 10:26 ET | 300 | 21.61 |
| 10:29 ET | 400 | 21.505 |
| 10:33 ET | 100 | 21.42 |
| 10:36 ET | 511 | 21.404 |
| 10:38 ET | 100 | 21.435 |
| 10:40 ET | 100 | 21.35 |
| 10:54 ET | 500 | 21.61 |
| 10:56 ET | 300 | 21.64 |
| 10:58 ET | 100 | 21.68 |
| 11:02 ET | 100 | 21.72 |
| 11:05 ET | 1000 | 21.75 |
| 11:14 ET | 400 | 21.77 |
| 11:16 ET | 733 | 21.82 |
| 11:20 ET | 700 | 21.7191 |
| 11:23 ET | 100 | 21.705 |
| 11:25 ET | 100 | 21.7 |
| 11:38 ET | 300 | 21.74 |
| 11:41 ET | 100 | 21.85 |
| 11:43 ET | 100 | 21.845 |
| 11:48 ET | 228 | 21.8 |
| 12:01 ET | 100 | 21.79 |
| 12:03 ET | 100 | 21.83 |
| 12:06 ET | 100 | 21.785 |
| 12:10 ET | 140 | 21.755 |
| 12:12 ET | 100 | 21.785 |
| 12:14 ET | 1400 | 21.82 |
| 12:17 ET | 100 | 21.9 |
| 12:19 ET | 1300 | 21.91 |
| 12:33 ET | 340 | 21.91 |
| 12:35 ET | 450 | 21.95 |
| 12:39 ET | 100 | 21.92 |
| 12:44 ET | 535 | 22.04 |
| 12:50 ET | 100 | 22.045 |
| 12:53 ET | 514 | 21.91 |
| 12:57 ET | 1200 | 21.8908 |
| 01:08 ET | 200 | 21.88 |
| 01:15 ET | 100 | 21.915 |
| 01:22 ET | 300 | 21.92 |
| 01:27 ET | 100 | 21.925 |
| 01:29 ET | 200 | 21.9 |
| 01:33 ET | 884 | 21.95 |
| 01:36 ET | 100 | 21.95 |
| 01:38 ET | 200 | 21.94 |
| 01:40 ET | 1090 | 21.8928 |
Today
Nov 7, 2023
Anika to Participate in Upcoming Investor Conferences, from 4:05PM ET on Tuesday Nov 07, 2023 by Dow Jones
4:05PM ET on Tuesday Nov 07, 2023 by Dow Jones
Nov 3, 2023
DJ Anika Therapeutics Up Over 11%, on Pace for Largest Percent Increase Since March 2020 -- Data Talk, from 12:26PM ET on Friday Nov 03, 2023 by Dow Jones
12:26PM ET on Friday Nov 03, 2023 by Dow JonesDJ Anika Therapeutics Is Maintained at Outperform by Barrington Research, from 12:14PM ET on Friday Nov 03, 2023 by Dow Jones
12:14PM ET on Friday Nov 03, 2023 by Dow Jones
Nov 2, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Anika Therapeutics Inc | 313.0M | -13.0x | --- |
Avid Bioservices Inc | 300.7M | -97.0x | --- |
Kamada Ltd | 274.2M | 39.3x | --- |
Poseida Therapeutics Inc | 261.1M | -1.8x | --- |
MacroGenics Inc | 474.5M | 9.5x | --- |
Alector Inc | 417.3M | -3.1x | --- |
Company Information
Anika Therapeutics, Inc. is a joint preservation company. The Company is engaged in creating and delivering advancements in early intervention orthopedic care, including osteoarthritis (OA) pain management, regenerative solutions, sports medicine and Arthrosurface joint solutions. The Company is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. The Company’s product line includes OA Pain Management, Joint Preservation and Restoration, and Non-Orthopedic. Its OA Pain Management product consists of Monovisc and Orthovisc, Cingal, and Hyvisc. Its Joint Preservation and Restoration consist of regenerative solutions, sports medicine, and Arthrosurface joint solutions. Monovisc and Orthovisc are single and multi-injection, HA-based Visco supplement products, Cingal, and Hyvis. Its Non-Orthopedic products consists of HA-based products that are marketed principally for non-orthopedic applications.
Contact Information
- Headquarters
- 32 Wiggins AveBEDFORD, MA, United States 01730-2315
- Phone
- 781-457-9000
- Fax
- 781-305-9720
Executives
- Independent Chairman of the Board
- Jeffery Thompson
- President, Chief Executive Officer, Director
- Cheryl Blanchard
- Chief Financial Officer, Executive Vice President, Treasurer
- Michael Levitz
- Chief Operations Officer, Senior Vice President
- Anne Nunes
- Executive Vice President, General Counsel, Secretary
- David Colleran
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $313.0M |
|---|---|
Revenue (TTM) | $163.3M |
Shares Outstanding | 14.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-1.68 |
Book Value | $19.53 |
P/E Ratio | -13.0x |
Price/Sales (TTM) | 1.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -18.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
